(FNOV) FT Cboe Vest U.S. Equity - Overview

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F8471

Etf: FLEX Options, S&P 500, ETF, Buffer, November

Total Rating 42
Risk 63
Buy Signal 1.36
Risk 5d forecast
Volatility 9.97%
Relative Tail Risk 2.43%
Reward TTM
Sharpe Ratio 0.70
Alpha 1.56
Character TTM
Beta 0.649
Beta Downside 0.663
Drawdowns 3y
Max DD 13.11%
CAGR/Max DD 1.07

Description: FNOV FT Cboe Vest U.S. Equity January 20, 2026

FNOV is a U.S.-based Defined-Outcome ETF that, under normal market conditions, allocates virtually all of its capital to FLEX Options linked to the SPDR S&P 500 ETF (SPY). FLEX Options are exchange-traded contracts that let the fund tailor strike prices, option style (American or European) and expiration dates, thereby shaping a predefined payoff profile while remaining non-diversified.

Key metrics to watch: the fund’s expense ratio sits around 0.75 % p.a., and its current assets under management are roughly $200 million. The typical option tenor is 12-18 months, which means the fund’s performance is highly sensitive to the term structure of S&P 500 implied volatility-a driver that tends to rise when the Federal Reserve tightens policy or when macro-economic uncertainty spikes. Because the underlying is a broad-market index, sector exposure mirrors the S&P 500, with technology and consumer discretionary comprising the largest weights.

For a deeper dive into how FNOV’s customized option structure translates into risk-adjusted returns, you might explore ValueRay’s analytical tools to benchmark its outcome profile against alternative defined-outcome strategies.

What is the price of FNOV shares?

As of February 09, 2026, the stock is trading at USD 55.35 with a total of 11,966 shares traded.
Over the past week, the price has changed by -0.22%, over one month by +0.29%, over three months by +2.85% and over the past year by +13.06%.

Is FNOV a buy, sell or hold?

FT Cboe Vest U.S. Equity has no consensus analysts rating.

What are the forecasts/targets for the FNOV price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 62.1 12.2%

FNOV Fundamental Data Overview February 04, 2026

Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.15b USD (1.15b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.15b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.15b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.31% (E(1.15b)/V(1.15b) * Re(8.31%) + (debt-free company))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for FNOV ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle